Another study showed that the levels of L1CAM in the blood were associated with lymph node metastasis and poor outcome [56], whereas another one showed no difference in L1CAM serum levels between L1CAM-positive and L1CAM-negative carcinomas [57]. The gene discussed is L1CAM; the disease is metastatic malignant neoplasm in the lymph nodes.